Skip to content
PubMed This is a summary of 15 peer-reviewed journal articles Updated
Neurology

The Diagnostic Workup: Tools and Checklists

At a Glance

Diagnosing early-onset spastic ataxia with myoclonic epilepsy and neuropathy uses several complementary tests. MRI, nerve studies, video-EEG, OCT, and broad genetic testing each reveal different clues; specialists interpret them together to identify an underlying cause such as ARSACS or a POLR3B-related disorder.

Confirming a diagnosis of early-onset spastic ataxia-myoclonic epilepsy-neuropathy syndrome requires a coordinated series of tests. Because this syndrome is a “clinical cluster” rather than a single disease, your doctors use these tools to look for specific “fingerprints” that point toward the underlying genetic cause, such as ARSACS or POLR3B-related disorders.

1. Neuroimaging: The Brain’s Map

A high-resolution Brain MRI is often the first major step. Doctors are not just looking for “general” changes; they are searching for very specific patterns:

  • Cerebellar Ataxia: In almost all cases of ARSACS and many related syndromes, the MRI shows cerebellar atrophy—a thinning of the part of the brain that controls balance and coordination [1][2].
  • The “Linear” Sign: A hallmark of ARSACS is the presence of linear pontine T2 hypointensities. These look like small, dark stripes in the pons (a part of the brainstem) on certain MRI views [1][3].
  • White Matter Changes: While these syndromes can mimic “leukodystrophies” (disorders of the brain’s white matter), the patterns of white matter loss in ARSACS are often widespread but lack the specific “defined” patterns seen in classic leukodystrophies [4].

2. Electrophysiology: Measuring Nerve Speed

Two tests, Nerve Conduction Studies (NCS) and Electromyography (EMG), are used to evaluate the neuropathy (nerve damage) component of the syndrome.

  • Demyelinating vs. Axonal: In ARSACS, the neuropathy is often demyelinating, meaning the protective coating on the nerves is damaged, which slows down the signals [5]. However, other versions of the syndrome may show axonal damage (damage to the nerve fiber itself) or a mixed pattern [1][6].
  • Monitoring: These tests provide a “baseline” to help doctors understand if the nerve damage is progressing and how it might be contributing to muscle weakness in the legs [7].

3. EEG: Capturing Seizure Patterns

An Electroencephalogram (EEG) is essential for managing the myoclonic epilepsy part of the syndrome.

  • Myoclonic-Atonic Seizures: Doctors look for patterns specific to particular epilepsy syndromes, such as generalized spike-wave discharges, which may be seen in some cases [8].
  • Video-EEG: Often, a “prolonged” or “video” EEG is used to record your child’s physical movements at the same time as their brain waves. This helps confirm if a “jerk” is a myoclonic seizure or a different type of movement, especially when the clinical event is uncertain [9].

4. The Retinal Exam: A Window to the Brain

In many children with the SACS gene mutation (ARSACS), the nerves in the back of the eye are affected in a very specific way.

  • OCT (Optical Coherence Tomography): This is a quick, non-invasive “camera” scan of the back of the eye, often targeted when ARSACS is suspected.
  • Nerve Thickening: Unlike many other neurological diseases that cause nerve thinning, ARSACS often causes the retinal nerve-fiber layer to become thickened [10][11]. Finding this thickening can be a very strong clue for the diagnosis, even before genetic results are back [12].

5. Genetic Testing: The Diagnostic Evidence

While MRI and EEG show the effects of the condition, genetic testing identifies the cause.

  • Why Panels and Exomes?: Because many different genes (like SACS, AFG3L2, POLR3B, and STUB1) can cause these symptoms, testing a single gene at a time is rarely efficient. Instead, doctors prefer Whole Exome Sequencing (WES) or large Movement Disorder Panels that look at hundreds of genes simultaneously [13][14]. However, genetic testing requires clinical correlation, and some patients may need deletion/duplication testing, genome sequencing, or repeat-expansion testing based on laboratory advice.
  • Checking the “Hidden” Areas: If standard exome testing is negative, your team may look for Copy Number Variants (CNVs)—missing or extra “chunks” of DNA—which are known to occur in the SACS gene [14][7].

Tests Your Team May Consider

Use this list to track whether your child’s workup has covered these conditional tests, depending on the clinical picture. Your team should also evaluate for treatable metabolic, nutritional, or mitochondrial mimics.

  • [ ] High-quality Brain MRI (specifically reviewing the pons and cerebellum)
  • [ ] Nerve Conduction Study (NCS) (to classify the type of neuropathy)
  • [ ] Video-EEG (to capture and classify seizure types)
  • [ ] Ophthalmology Exam with OCT (to check for retinal nerve thickening)
  • [ ] Comprehensive Genetic Testing (Exome or a broad Spastic Ataxia panel)
  • [ ] Carrier Testing for Parents (to confirm the inheritance pattern)
  • [ ] Swallowing Evaluation (if there are any concerns about choking or coughing) [15]

Common questions in this guide

What can a brain MRI show in ARSACS or related spastic ataxia syndromes?
A brain MRI may show cerebellar atrophy, or thinning of the brain area that helps control balance and coordination. In ARSACS, doctors may also look for linear dark areas in the pons and review white-matter patterns, but MRI findings alone do not establish the genetic diagnosis.
What do nerve conduction studies and EMG tell doctors?
These tests assess peripheral nerve function and help classify neuropathy as demyelinating, axonal, or mixed. In ARSACS, demyelinating neuropathy is common, and the results can provide a baseline for tracking nerve damage and leg weakness.
Why might my child need a video EEG?
A video EEG records brain-wave activity and physical movements at the same time. It can help determine whether jerking episodes are myoclonic seizures and identify seizure patterns such as generalized spike-wave discharges.
How can an OCT eye scan help diagnose ARSACS?
OCT is a quick, noninvasive scan of the back of the eye. In children with ARSACS, thickening of the retinal nerve-fiber layer can be a useful diagnostic clue, sometimes before genetic results are available.
What genetic tests may be needed if initial testing is negative?
Because several genes can cause this clinical cluster, doctors may use a broad movement-disorder or spastic-ataxia panel or whole-exome sequencing instead of testing one gene at a time. If results are negative, the team may consider deletion and duplication testing, copy-number testing, genome sequencing, or repeat-expansion testing based on the clinical findings and laboratory advice.
When might a swallowing evaluation be part of the workup?
A swallowing evaluation may be considered if a child coughs or chokes while eating or drinking, because swallowing problems can affect safety and nutrition. It is a conditional test and is not needed for every child.

Get notified when new evidence is published on Early-onset spastic ataxia-myoclonic epilepsy-neuropathy syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (15)
  1. 1

    Clinical and Molecular Findings of Autosomal Recessive Spastic Ataxia of Charlevoix Saguenay: an Iranian Case Series Expanding the Genetic and Neuroimaging Spectra.

    Ashrafi MR, Mohammadi P, Tavasoli AR, et al.

    Cerebellum (London, England) 2023; (22(4)):640-650 doi:10.1007/s12311-022-01430-3.

    PMID: 35731353
  2. 2

    Clinical, ophthalmological, imaging and genetic features in Brazilian patients with ARSACS.

    Rezende Filho FM, Parkinson MH, Pedroso JL, et al.

    Parkinsonism & related disorders 2019; (62()):148-155 doi:10.1016/j.parkreldis.2018.12.024.

    PMID: 30638817
  3. 3

    Widening the clinical, radiological and genetic spectrum of autosomal recessive ataxia of Charlevoix-Saguenay in Indian patients.

    Divya KP, Cherian A, Dhing HK, et al.

    Acta neurologica Belgica 2024; (124(2)):475-484 doi:10.1007/s13760-023-02400-0.

    PMID: 37898963
  4. 4

    An MRI evaluation of white matter involvement in paradigmatic forms of spastic ataxia: results from the multi-center PROSPAX study.

    Scaravilli A, Gabusi I, Mari G, et al.

    Journal of neurology 2024; (271(8)):5468-5477 doi:10.1007/s00415-024-12505-y.

    PMID: 38880819
  5. 5

    Neuropathy in ARSACS is demyelinating but without typical nerve enlargement in nerve ultrasound.

    Kneer K, Straub S, Wittlinger J, et al.

    Journal of neurology 2024; (271(5)):2494-2502 doi:10.1007/s00415-023-12159-2.

    PMID: 38261029
  6. 6

    SACS variants are a relevant cause of autosomal recessive hereditary motor and sensory neuropathy.

    Vill K, Müller-Felber W, Gläser D, et al.

    Human genetics 2018; (137(11-12)):911-919 doi:10.1007/s00439-018-1952-6.

    PMID: 30460542
  7. 7

    Frameshift and Copy Number Variants in SACS-Related Neuropathy.

    Yuan JH, Higuchi Y, Ando M, et al.

    Neurology. Genetics 2025; (11(6)):e200318 doi:10.1212/NXG.0000000000200318.

    PMID: 41164123
  8. 8

    Epilepsy with myoclonic-atonic seizures, also known as Doose syndrome: Modification of the diagnostic criteria.

    Oguni H

    European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society 2022; (36()):37-50 doi:10.1016/j.ejpn.2021.11.009.

    PMID: 34883415
  9. 9

    A case of epilepsy with myoclonic atonic seizures caused by SLC6A1 gene mutation due to balanced chromosomal translocation.

    Mori T, Sakamoto M, Tayama T, et al.

    Brain & development 2023; (45(7)):395-400 doi:10.1016/j.braindev.2023.03.001.

    PMID: 36966012
  10. 10

    Clinical and genetic variability among Bulgarian patients with autosomal recessive spastic ataxia of Charlevoix-Saguenay.

    Chamova T, Ivanova N, Cherninkova S, et al.

    Molecular genetics & genomic medicine 2024; (12(7)):e2483 doi:10.1002/mgg3.2483.

    PMID: 39044368
  11. 11

    Journey Through Autosomal-Recessive Spastic Ataxia of Charlevoix-Saguenay: Insights From a Case Series of Seven Patients-A Single-Center Study and Review of an Indian Cohort.

    Raval MA, Holla VV, Kamble N, et al.

    Journal of movement disorders 2024; (17(4)):430-435 doi:10.14802/jmd.24154.

    PMID: 39198013
  12. 12

    ARSACS as a Worldwide Disease: Novel SACS Mutations Identified in a Consanguineous Family from the Remote Tribal Jammu and Kashmir Region in India.

    Kuchay RAH, Mir YR, Zeng X, et al.

    Cerebellum (London, England) 2019; (18(4)):807-812 doi:10.1007/s12311-019-01028-2.

    PMID: 30963395
  13. 13

    Children with suspected hereditary spastic paraplegia clearly benefit from whole exome analysis.

    Safka Brozkova D, Paulasova Schwabova J, Vyhnalkova E, et al.

    Human genomics 2026; (20(1)).

    PMID: 41749354
  14. 14

    Clinical and genetic spectra of 1550 index patients with hereditary spastic paraplegia.

    Méreaux JL, Banneau G, Papin M, et al.

    Brain : a journal of neurology 2022; (145(3)):1029-1037 doi:10.1093/brain/awab386.

    PMID: 34983064
  15. 15

    Coordination and timing deficits in speech and swallowing in autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS).

    Vogel AP, Rommel N, Oettinger A, et al.

    Journal of neurology 2018; (265(9)):2060-2070 doi:10.1007/s00415-018-8950-4.

    PMID: 29968200

This page is for informational purposes only and does not constitute medical advice. Your child's neurologist and genetics team should decide which tests are appropriate and interpret the results for your child's situation.